The linked FDA records tie LeMaitre Vascular, Inc. to two device lines. One is the Artegraft Collagen Vascular Graft, filed under PMA number N16837 with product code LXA and classified as a tissue graft of 6 mm and greater. The other is the TufTex Over-the-Wire Embolectomy Catheter, catalog number E1651-88, named in a Class II recall. The collection holds two PMA supplement records, one decided OK30 and one APPR, and a separate recall entry. [1][2][3]

Artegraft graft and its documented identity

Artegraft appears in FDA data as a tissue graft of 6 mm and greater, device class 3, under product code LXA, with the cardiovascular advisory committee recorded on both supplements. LeMaitre's own product page describes Artegraft as a bovine carotid artery graft whose biological fibrous matrix is processed to provide a cross-linked conduit, and lists functional hemodialysis access and lower extremity bypass among its applications. [1][2][7]

The instructions for use list model numbers AG540, AG630, AG636, AG640, AG645, AG715, AG730, AG735, AG740, AG745, AG750, AG830, AG840, AG845, AG1015 and AG1030. The same document states the graft is of biological origin, is preserved in a tube filled with USP purified water and ethyl alcohol, and is not made with natural rubber latex. A symbol legend records liquid chemical sterilization compliant to EN/ISO 14160 and an MR Safe marking. [5][10]

Recent PMA supplement activity

Supplement S039 was received 2026-08-06 and decided APPR on 2026-09-04. Its supplement type is Special (Immediate Track) and its stated reason is a labeling change covering indications, instructions, shelf life or tradename. The applicant office statement describes approval of a new warning and other labeling changes in the Instructions for Use for the Artegraft Collagen Vascular Graft. [2]

Supplement S040 was received 2026-09-15 and decided OK30 on 2026-10-15 as a 30-Day Notice. Its supplement reason is a process change involving manufacturer, sterilizer, packager or supplier, and the office statement describes an additional service supplier to perform routine bioburden testing on the graft. Neither supplement carries an expedited review flag. [1]

Recall record for the TufTex catheter

Recall Z-0117-2027 covers the TufTex Over-the-Wire Embolectomy Catheter, catalog number E1651-88, lot XOT00002181, with 54 units recorded. FDA classifies it Class II, status Ongoing, firm-initiated and voluntary, with a recall initiation date of 2026-08-28 and a center classification date of 2026-10-07. The stated reason is that devices failed in process testing related to the amount of pull force sustained prior to balloon component failure. [3]

The distribution pattern recorded for that recall is US nationwide distribution in CA, FL, GA, KY, LA, NJ, OH, PA and SC, with initial firm notification by letter. The recall entry does not describe the catheter's indications, design or clinical performance. [3]

How to read the filing counts

The collection totals two linked PMA records, one decided OK30 and one APPR. The smaller record sample contains the same two decisions, so the sample counts match the collection counts here. These figures describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1][2]

The FDA filing address shown on both supplements is in Burlington, Massachusetts, and the recall entry lists a Burlington address as well. Those are filing and recall addresses in the records, not a verified corporate headquarters. The instructions for use name LeMaitre Vascular, Inc. as distributor and carry customer service contact details, and a European instructions document lists additional LeMaitre entities and representatives; no parent or brand ownership is established by these sources. [1][2][3][5][8]